New Government Subsidy Program Announced: Up to 60% R&D Cost Reimbursement for Foreign-Invested Enterprises

The Ministry of Finance and Ministry of Industry and Information Technology have jointly released the “Advanced Manufacturing Reimbursement Program 2025,” offering foreign-invested enterprises (FIEs) a maximum of RMB 10 million per project — equivalent to 60% of eligible R&D expenditures. This program, effective from August 1, 2025, targets semiconductor, green energy, and biotechnology sectors, and marks a significant expansion over the previous 2024 program that capped reimbursement at 40% coverage and RMB 5 million. For foreign executives evaluating China market entry or expansion, this decision tool update provides the key numbers, application timeline, and strategic implications necessary to act quickly.

Program Overview and Key Numbers

The subsidy is administered under the 14th Five-Year Plan for Advanced Manufacturing, with a total budget of RMB 5 billion — up from RMB 3 billion in 2024. The program expects to fund 200 projects in 2025, compared to 150 in the prior cycle. Eligible enterprises include wholly foreign-owned enterprises (外商独资企业, WFOE, wàishāng dúzī qǐyè), joint ventures, and Chinese-owned companies, but the key change is that FIEs now qualify for the maximum 60% reimbursement rate, which was previously reserved for domestic firms. The reimbursement covers direct R&D labor, equipment depreciation, third-party testing, and intellectual property registration costs up to the cap amount.

A critical contextual number: the application window is only 60 days — from August 1 to September 30, 2025 — compared to the 90-day window in 2024. This compressed timeline means foreign executives must begin documentation preparation immediately. Additionally, the program prioritizes projects with “clear commercial deployment within 18 months,” a requirement that aligns with China’s push for rapid industrialization of new technologies.

Comparison with Previous Subsidy Programs

To aid decision-making, the table below compares the 2025 program against the 2024 R&D reimbursement initiative. This comparison highlights the increased budget, wider sector eligibility, and tightened application timeline that foreign firms must navigate.

This comparison reveals three strategic takeaways. First, the 2025 program offers 2x the maximum subsidy per project with a higher reimbursement rate, making it more attractive for FIEs with large-scale R&D plans. Second, the sector expansion from “semiconductors only” to include green energy and biotech opens new opportunities for foreign firms in those verticals. Third, the shorter application window and stricter commercialization timeline require faster internal coordination and more precise project planning.

Application Process and Critical Timeline

The application is submitted through the Ministry of Industry and Information Technology’s online portal (www.miit.gov.cn/subsidy2025), with mandatory supporting documents including: (1) a detailed R&D project plan, (2) audited financial statements showing R&D expenditure history, (3) proof of WFOE or JV registration in China, and (4) a commercialization roadmap with milestone dates. Deadline: September 30, 2025, at 23:59 Beijing time. The review process takes 45 business days, with results announced by November 30, 2025. Disbursement occurs in two tranches — 70% upfront and 30% upon completion of project milestones.

Foreign executives should note that the portal requires Chinese-language submissions prepared in accordance with the Circular on R&D Expenditure Recognition Standards 2025. Legal translations of foreign-language documents must be notarized. Given that the window opens in less than two months from the announcement date (June 2, 2025), firms without a local China entity or established accounting systems face the highest risk of missing the deadline.

Strategic Implications for Foreign Executives

For decision-makers evaluating whether to pursue this subsidy, the program signals Beijing’s continued commitment to attracting foreign R&D investment despite broader regulatory tightening. The inclusion of FIEs at the 60% reimbursement rate — historically reserved for domestic firms — reduces the effective cost of innovation in China by up to 20 percentage points compared to 2024. However, the commercialization requirement within 18 months means projects must be closer to market readiness than in previous years. If your company has a proven R&D pipeline in semiconductors, green energy, or biotechnology, this program can significantly accelerate ROI. If your project is still in early-stage research, the 2024 program’s 24-month deployment timeline was more lenient — though that program is now closed.

Decision framework: If your WFOE or JV has a technology project with a prototype or pilot stage completed, and you can demonstrate commercial revenue within 18 months of funding, submit an application. If your project is pure research with no clear market path, wait for potential future programs or consider provincial-level subsidies that may have longer timelines.

Pitfall: Incomplete R&D Cost Categorization

Pitfall: Missing the Notarization Requirement for Foreign Documents

Pitfall: Misjudging the Commercial Deployment Timeline

NEXT STEPS

1. Assess Your Project Eligibility: Read our comprehensive FIE Registration and R&D Qualification Guide to confirm your WFOE structure meets the ownership and sector requirements.
2. Prepare Financial Documentation: Download our R&D Accounting and Audit Checklist for Foreign Firms to ensure your expenditure categorization aligns with MIIT standards.
3. Secure Application Support: Contact our China Subsidy Advisory Team for hands-on document preparation, submission, and milestone tracking support specifically for this 2025 program.